Hey All, I just got my lab results from blood drawn on 7-28-15. This is part of a long term (3 year) follow up of patients who achieved SVR in a clinical trial. The Merck trial number was MK5172-068. Each tablet, (#84 in all, 12 weeks of tx), consisted of Grazoprevir 100mg., and Elbasvir 50 mg. This med produced a 97%+ SVR in patients with GTs1,1a, 4 and 6. Results were basically identical in both cirrhotic and non-cirrhotic trial participants. It has been Mid November, 2014 since my last dose. The 7-28-15 lab results:
Viral Titer = TND ALT = 29, ALK PHOS = 152 (H), AST = 32. The ALK PHOS will never be WNL because of my extensive cirrhosis (Stage 5). No improvement of lower limb circulatory issues has been noted since cessation of tx. Spontaneous liver tissue regeneration may be impossible at this point, the tight rope I will walk until The Big Sleep is whether I can stay off the donor list or not. Look for Merck to slap a name on this med, and it be available before the year is out. The FDA has already awarded, rescinded, then awarded again "breakthrough" status for this as of yet unnamed medication. I experienced no side efx at all. Mac790